Overview

Topical Tacrolimus in Vernal Keratoconjunctivitis

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The main aim of this study is to evaluate the efficacy and safety of topical tacrolimus 0.01% eyedrops in patients with vernal keratoconjunctivitis.
Phase:
Phase 4
Details
Lead Sponsor:
The Eye Center and The Eye Foundation for Research in Ophthalmology
Treatments:
Tacrolimus